Literature DB >> 19356107

Covariates of amikacin clearance in neonates: the impact of postnatal age on predictability.

Karel Allegaert1, Isabelle Scheers, Veerle Cossey, Brian J Anderson.   

Abstract

An earlier reported population pharmacokinetic study documented limited predictability of amikacin clearance (65%) at birth. An exercise in the first month of life resulted in extended predictability (92%) with similar clearance estimates after the first postnatal days, reflecting the impact of postnatal age on clearance predictability.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19356107     DOI： 10.2174/187231208786734157

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN： 1872-3128


  9 in total

1.  Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease.

Authors:  Amy L Nguyen; Peter N Johnson; Stephen B Neely; Kaitlin M Hughes; Kris C Sekar; Robert C Welliver; Jamie L Miller
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

2.  Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis.

Authors:  Sílvia M Illamola; Hoa Q Huynh; Xiaoxi Liu; Zubin N Bhakta; Catherine M Sherwin; Theodore G Liou; Holly Carveth; David C Young
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

3.  Quantification of amikacin in bronchial epithelial lining fluid in neonates.

Authors:  C Tayman; M N El-Attug; E Adams; A Van Schepdael; A Debeer; K Allegaert; A Smits
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 4.  Clinical Pharmacokinetics of Amikacin in Pediatric Patients: A Comprehensive Review of Population Pharmacokinetic Analyses.

Authors:  Sílvia M Illamola; Catherine M Sherwin; J G Coen van Hasselt
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447

5.  Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol.

Authors:  Kaitlin M Hughes; Peter N Johnson; Michael P Anderson; Kris C Sekar; Robert C Welliver; Jamie L Miller
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

6.  Maturation of the glomerular filtration rate in neonates, as reflected by amikacin clearance.

Authors:  Roosmarijn F W De Cock; Karel Allegaert; Michiel F Schreuder; Catherine M T Sherwin; Matthijs de Hoog; Johannes N van den Anker; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2012-02-01       Impact factor: 6.447

7.  Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies.

Authors:  Sílvia M Illamola; Helena Colom; J G Coen van Hasselt
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

8.  High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination.

Authors:  Tuuli Metsvaht; Georgi Nellis; Heili Varendi; Anthony J Nunn; Susan Graham; Andre Rieutord; Thomas Storme; James McElnay; Hussain Mulla; Mark A Turner; Irja Lutsar
Journal:  BMC Pediatr       Date:  2015-04-16       Impact factor: 2.125

9.  Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias.

Authors:  Farzaneh Salem; Trevor N Johnson; Arran B J Hodgkinson; Kayode Ogungbenro; Amin Rostami-Hodjegan
Journal:  J Clin Pharmacol       Date:  2020-09-03       Impact factor: 3.126
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.